| 查看: 358 | 回复: 0 | |||
myIDname木虫 (著名写手)
人民大会堂首席清洁工
|
[交流]
2012/12/21 news of the week@SCIENCE 之三:德克萨斯州癌症研究所继续深化改革
|
|
本周第三条,原文链接:http://www.sciencemag.org/content/338/6114/1516.1.full.pdf Austin 3 More Changes at Texas Cancer Agency 德克萨斯州癌症研究所继续深化改革 William Gimson, the executive director of the troubled $3 billion Cancer Prevention and Research Institute of Texas (CPRIT), stepped down last week. The agency also announced a new chief scientific officer to replace Alfred Gilman, the Nobel laureate who quit in protest over the agency’s peer review procedures. Gimson explained in a letter to CPRIT’s board that after 8 months of controversy, he has “been placed in a situation where I feel I can [no] longer be effective.” His resignation follows the departure of CPRIT Chief Commercialization Officer Jerald Cobbs in November. 投资30亿美元的德克萨斯州癌症预防研究所动荡不安,执行董事William Gimson上周辞职。该研究所还指派新的首席科学家来替代诺贝尔奖获得者Alfred Gilman,他因为对研究所(基金项目)预审流程的抗议而辞职。历时8个月的争论之后,Gimson写信给CPRIT董事会解释说,他已经“被置于一个自己觉得不在有用的处境。”CPRIT首席市场化执行官Jerald Cobbs11月前脚走人,Gimson后脚紧跟着辞职。 Last week, the Travis County district attorney launched a criminal investigation into CPRIT’s funding of several commercialization awards. CPRIT’s new chief scientist is Margaret Kripke, a cancer immunologist and former executive vice president at the University of Texas MD Anderson Cancer Center in Houston. She told reporters that her first task will be to rebuild CPRIT’s “really terrific” peer review system, which lost many reviewers when Gilman left in October. 上周,Travis镇地区检察官启动了对CPRIT几笔商业化奖励基金的刑事侦查。CPRIT的新任首席科学家是癌症免疫学家Margaret Kripke,同时也是休斯顿德克萨斯州大学MD Anderson癌症研究中心的前任副主席。她告诉记者说,她的首要任务将会是重建CPIRT“非常了不起的”预审体系,许多评审人在10月份Gilman走后都流失掉了。 *************************************************************** Science的原文和本翻译仅用于网友交流学习之用,若您有其它用途,比如商业用途等,请联系Science杂志社了解原文使用权等相关事宜。谢谢! |
» 猜你喜欢
电子信息270求调剂
已经有18人回复
食品与营养(0955)271求调剂
已经有5人回复
0831生医工第一轮调剂失败求助
已经有14人回复
279学硕食品专业求调剂院校
已经有13人回复
293求调剂
已经有11人回复
322求调剂
已经有13人回复
272分材料子求调剂
已经有50人回复
295分求调剂
已经有13人回复
339求调剂
已经有9人回复
一志愿哈工大 085600 277 12材科基求调剂
已经有28人回复














回复此楼